Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Psychopharmacology Bulletin|July 25, 2009
Desvenlafaxine and venlafaxine exert minimal in vitro inhibition of human cytochrome P450 and P-glycoprotein activitiesAram Oganesian, Adam D Shilling, Ruth Young-Sciame, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 28, 2016
Clearance Prediction of Targeted Covalent Inhibitors by In Vitro-In Vivo Extrapolation of Hepatic and Extrahepatic Clearance MechanismsLouis Leung, Xin Yang, Timothy J Strelevitz, et al.
Chemical Research in Toxicology|September 19, 2019
Moving beyond Binary Predictions of Human Drug-Induced Liver Injury (DILI) toward Contrasting Relative Risk PotentialMichael D Aleo, Falgun Shah, Scott Allen, et al.
Bioorganic & Medicinal Chemistry Letters|February 16, 2010
Optimization of 5-vinylaryl-3-pyridinecarbonitriles as PKCtheta inhibitorsDiane H Boschelli, Joan Subrath, Chuansheng Niu, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2009
C-5 substituted heteroaryl-3-pyridinecarbonitriles as PKCtheta inhibitors: part IIAmar S Prashad, Daniel Wang, Joan Subrath, et al.
Neuro-Degenerative Diseases|August 28, 2012
Cerebrospinal fluid β-Amyloid turnover in the mouse, dog, monkey and human evaluated by systematic quantitative analysesYasong Lu, Hugh A Barton, Louis Leung, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 8, 2012
Cerebrospinal fluid amyloid-β (Aβ) as an effect biomarker for brain Aβ lowering verified by quantitative preclinical analysesYasong Lu, David Riddell, Eva Hajos-Korcsok, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 8, 2016
Evaluation of a New Molecular Entity as a Victim of Metabolic Drug-Drug Interactions-an Industry PerspectiveTonika Bohnert, Aarti Patel, Ian Templeton, et al.
Pageof 4